1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Mitsubishi Chemical Group Corporation

Mitsubishi Chemical Group Corporation

MTLHF
Mitsubishi Chemical Group CorporationUS flagOther OTC
6.26
USD
- -
- -
8.50BMarket Cap
Mitsubishi Chemical Group Corporation
MTLHF
(Other OTC)

Recent

price

6.26

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
2,224.86
2,176.08
2,095.16
2,376
2,487.27
2,418.98
2,306.04
2,587.58
2,700.63
2,521.52
2,293.63
2,798.81
3,259.66
3,083.99
2,774.34
2,702.29
1,572.66
Revenue per Share
58.72
24.07
12.61
21.9
41.4
35.06
106.73
147.14
119.22
38.08
-5.32
124.68
67.85
84.07
31.64
8.63
36.82
Basic EPS, GAAP
121.84
69.17
48.32
28.48
115.03
55.08
130.37
117.89
130.09
152.06
147.94
62.78
52.18
134.03
160.15
105.17
85.23
Free Cash Flow per Basic Share
8.69
10.01
11.01
12.02
12
14
16.01
27
37.18
40
24
27
30
31
32
32.47
16
Dividend per Share
352.64
355.95
358.91
369.16
430.47
451.19
554.21
699.59
790.34
789.63
781.6
889.32
928.82
987.74
993.54
1,013.47
1,000.64
Book Value per Share
623.29
635.42
649.94
691.54
788
773.32
791.03
861.6
568.39
227.81
312.58
485.66
563.8
675.93
713.29
836.07
698.45
Tangible Book Value per Share
1,423
1,474
1,474
1,473
1,470
1,465
1,464
1,439
1,422
1,420
1,420
1,421
1,422
1,423
1,423
1,371
1,423
Basic Weighted Avg Shares
3,166,771
3,208,168
3,088,577
3,498,834
3,656,278
3,543,352
3,376,057
3,724,406
3,840,341
3,580,510
3,257,535
3,976,948
4,634,532
4,387,218
3,947,566
3,703,988
2,237,320
Sales/Revenue/Turnover
7.15
4.07
2.92
3.16
4.53
7.19
7.45
8.84
6.98
3.66
0.98
7.09
3.69
5.78
3.39
0.87
5.33
Operating Margin (%)
158,405
157,979
141,382
146,279
172,397
182,656
174,040
178,895
199,332
239,824
243,793
251,469
269,616
275,436
275,933
271,157
139,805
Depreciation Expense
83,581
35,486
18,596
32,248
60,859
51,358
156,259
211,788
169,530
54,077
-7,557
177,162
96,461
119,596
45,020
11,829
52,384
Net Income, GAAP
27.7
41.68
48.41
48.32
41.76
29.3
17.19
19.68
24.78
42.9
30.95
27.88
19.3
25.82
41.49
2,400.28
23.64
Effective Tax Rate (%)
2.64
1.11
0.6
0.92
1.66
1.45
4.63
5.69
4.41
1.51
-0.23
4.45
2.08
2.73
1.14
0.32
2.34
Profit Margin (%)
251,085
307,580
202,882
304,044
241,372
415,015
618,476
604,771
128,541
112,782
305,028
566,823
485,788
466,724
561,402
694,346
513,606
Working Capital
827,977
767,798
653,222
692,729
859,216
872,870
1,116,005
1,025,268
1,138,108
1,555,947
1,696,029
1,748,756
1,642,325
1,595,704
1,612,920
1,503,457
1,558,863
LT Debt
1,114,003
1,144,954
1,203,316
1,314,870
1,602,380
1,596,151
1,698,197
1,919,490
2,025,854
1,450,829
1,571,148
1,844,319
1,988,469
2,275,495
2,284,569
2,414,680
2,257,968
Total Equity
6.61
3.19
1.96
2.27
3.31
5.58
6.29
7.57
5.12
1.86
0.57
5.1
3.32
4.3
1.77
-17.1
2.02
Return on Invested Capital (%)
2.56
0.28
0.1
0.59
1.4
0.54
3.7
5.14
3.78
1
-0.59
4.23
2.12
2.32
0.34
-23.76
0.99
Return on Capital (%)
17.95
6.91
3.53
6.01
10.35
7.94
21.23
23.3
15.91
4.82
-0.68
14.93
7.47
8.78
3.19
0.84
3.75
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
605,307
- -
533,855
LT Borrowings
1,595,704
- -
1,558,863
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,423
- -
1,423
Market Capitalization
1,363,585
1,234,354
1,349,635

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
2,191,636
- -
2,152,336
Cash, Cash Equivalents & STI
377,728
- -
352,092
Accounts Receivable, Net
852,353
- -
761,072
Inventories
799,249
- -
808,784
Total Current Liabilities
1,724,912
- -
1,638,730
Payables & Accruals
- -
- -
- -
ST Debt
605,307
- -
533,855
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.06%
9.15%
5.7%
Free Cash Flow
21.39%
13.08%
-36.74%
Net Income, GAAP
-256.42%
-520.4%
-73.73%
Sales/Revenue/Turnover
1%
3.42%
-6.17%
Total Cash Common Dividend
11.17%
5.62%
-2.25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,061,242
1,088,656
1,095,242
1,142,078
4,387,218
2025
- -
- -
- -
- -
3,947,566
2026
- -
- -
- -
- -
3,703,988

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29.91
17.35
25.77
- -
84.07
2025
- -
- -
- -
- -
31.64
2026
- -
- -
- -
- -
8.63

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
15
- -
16
- -
31
2025
- -
- -
- -
- -
32
2026
- -
- -
- -
- -
32.47
Similar Companies
Venlon Enterprises Limited (VENLONENT.BO)
Lotte Chemical Titan Holding Berhad (5284.KL)
Hoshine Silicon Industry Co., Ltd. (603260.SS)
Hazer Group Limited (HZRGF)
Zhejiang Runyang New Material Technology Co., Ltd. (300920.SZ)
Zhejiang Guanghua Technology Co., Ltd. (001333.SZ)
Business
Mitsubishi Chemical Group Corporation (TSE:4188; OTC:MTLHF) operates as a diversified global specialty chemicals holding company, developing and manufacturing advanced materials across performance products, industrial chemicals, and industrial gases. Core products and services encompass chemicals including petrochemical intermediates; polymers, resins, and high-performance chemicals; plastic molded and processed products such as films, sheets, moldings, and composites; carbon fibers and composite materials; information, electronics, display, and battery materials; inorganic products including alumina fibers; fibers and textiles; environment and living solutions; agriculture, food materials, healthcare products; and service, IT, and analysis solutions. The company serves industries including automotive, aerospace, electronics, packaging, healthcare, agriculture, and energy, with operations spanning Asia-Pacific, North America, Europe, and over 30 countries worldwide; it maintains headquarters in Tokyo, Japan, where Mitsubishi Chemical Corporation traces origins to 1933 and the group formed via merger in 2005. Recent strategic developments include the February 2025 agreement to divest its pharmaceutical subsidiary Mitsubishi Tanabe Pharma to Bain Capital for approximately $3.4 billion, enabling sharper focus on core chemicals and materials businesses amid ongoing investments in research, development, and capacity expansions. In July 2025, Diamond Edge Ventures, the corporate venture capital arm of the group, provided strategic funding to Licella under a Business and Capital Alliance Agreement to advance commercial projects in sustainable aviation fuel and advanced recycling using Cat-HTR+ technology. Second-quarter 2025 earnings highlighted progress on ¥360 billion in structural reforms toward a ¥400 billion target, alongside capacity expansions for carbon fiber composites in Italy and barrier packaging materials in the UK, with upward revisions to four-year forecasts for specialty materials segments.

Company News

APIChatGPT

  • businesswire.com

    Mitsubishi Chemical and Accenture Establish Joint Venture to Drive AI-Enabled Business Reinvention and Operational Transformation

  • seekingalpha.com

    Mitsubishi Chemical Group Corporation (MTLHY) Q4 2026 Earnings Call Transcript